Although wild-type polyoma virus does not productively infect murine embryonal carcinoma (EC) cells, a number of mutants (PyEC mutants) that do infect undifferentiated EC cells have been isolated. All PyEC mutants have DNA sequence alterations within the enhancer region of the viral genome. This report describes an activity present in nuclear extracts of F9 EC cells which, by "footprint" analyses, binds specifically to a small region of about 20 base pairs (nucleotides 5180-5200) within the subregion of the polyoma enhancer designated as the B or 6 element. While no difference in binding of factor was detected between wild-type polyoma enhancer and the enhancers of the PyEC mutants, PyFlll and PyF441, which had been selected for productive infection of F9 cells, definite differences between wild-type and mutants were observed in the digestion patterns of their naked DNAs with either DNAase I or exonuclease III. This difference was restricted to the region around the point mutation (nucleotide 5258) common to these mutant DNAs.
INTRODUCTION
Enhancers are operationally defined as DNA sequences that stimulate transcription of cis-1inked genes in a manner relatively independent of location and orientation (1). Sequences having enhancer activity have been found in a number of viral genomes including, but not limited to, those of simian virus (SV) 40 (2-5), polyoma virus (6), and bovine papilloma virus (BPV; 7,8). Enhancer sequences have also been identified in some eukaryotic cellular genes (9-12). Several studies suggest that enhancers are involved in cell type-specific gene expression, either with respect to species (4,13-15) or to differentiation state (9,10,12,16), but more recent evidence (17) (18) (19) (20) (21) (22) (23) indicates that enhancer sequences by themselves may not be sufficient for cell type-specific control of transcription. It appears that the cooperative interaction of several genetic elements must occur for regulated gene expression. A number of observations (24-28) suggest the interaction of transacting factors with enhancer sequences, but no factor exhibiting cell type specificity with respect to enhancer function has yet been isolated. Thus, sequences within the Pvu 11-4 fragment, accompanied by duplication and translocation of sequences within the A/a element of the polyoma enhancer (44) . Polyoma mutants isolated on murine trophoblast cells differ from the PyEC mutants by having deletions in the region between the A/a and B/6 elements (48). Polyoma mutants selected on murine neuroblastoma and Friend cells contain direct tandem duplications of varying lengths within the A/a element (49-51). Duplication of enhancer sequences p_er s£ does not necessarily lead to altered host range properties as several natural variants of polyoma virus with wild-phenotype contain tandem duplications of sequences within the enhancer (53) .
Because specific DNA sequence alterations within the polyoma enhancer affect the host range properties of the the virus, this laboratory has been searching for factors in EC cells that specifically interact with the enhancer region of polyoma DNA. The rationale for this search is that identification and characterization of such factors could provide information relevant to regulatory mechanisms affecting viral gene expression or DNA replication, which in turn may be relevant to mechanisms related to cellular gene expression or DNA replication during growth and differentiation of EC cells. I describe an activity present in nuclear extracts of F9 EC cells that specifically binds to the enhancer region of polyoma DNA. Analyses by filter binding and by "footprinting" with DNAase I and with exonuclease (Exo) III map the binding site to a small region within the B/B element of the polyoma enhancer. The activity binds to the DNAs of wild-type polyoma and the PyEC mutants, PyFlll and PyF441, which had been selected for growth in undifferentiated F9 cells, and thus, cannot account for the host range specificity of these mutants. However, nuclease digestion analyses of naked DNAs suggest an inherent structural difference between wild-type and PyF441 DNAs that can be distinguished by either DNAase I or Exo III. This structural difference is located in the region around the PyF441 point mutation in the B/6 element of the polyoma enhancer.
MATERIALS AND METHODS

Cells and Viruses
Methods for culture and infection of mouse F9 EC cells and 3T6 cells, and wild-type polyoma strain A3 and the PyEC(F9) mutants, F101, Fill and F441, were described previously (42). PyF441 has a point mutation at nucleotide 5258. PyFlOl and PyFlll have tandem duplications of 54 and 31 bp, respectively, of sequences encompassing the point mutation with both copies of the duplications containing the point mutation.
Buffers and Solutions
TBS is 140 ITIM NaCl, 5 mM KC1, 7 mM Na 2 HP0 4 , 0.1% glucose, 50 mM Tris, adjusted to pH 7.4 with HC1. Lysis buffer (54) contains 10 mM HEPES, 0.5 mM spermidine, 0.15 mM spermine, 1 mM EDTA, 0.25 mM EGTA, 500 mM sucrose, 50 mM NaCl, 7 mM 2-mercaptoethanol, 0.003 TlU/ml aprotinin, 0.5 mM PMSF, adjusted to pH 8 with NaOH. Extraction buffer is identical to lysis buffer except that 101 glycerol is substituted for sucrose. Tris-acetate buffer is 40 mM Tris, 5 mM sodium acetate, 1 mM EDTA, adjusted to pH 7.8 with acetic acid. TBE (55) is 89 mM Tris, 89 mM boric acid, 2 mM EDTA. Preparation of Nuclear Extracts F9 cells were grown in 15 cm plates to a density of 2-5x10 and washed once with cold TBS. All further procedures were performed at 0-4°. The cells were harvested by scraping with a rubber policeman into TBS and collected by centrifugation at 2000xg for 10 min. The cells were washed by suspension and centrifugation in lysis buffer, then suspended in lysis buffer containing 0.05% NP-40. Cell lysis was monitored by phase microscopy. Upon nearly complete release of nuclei, the lysate was centrifuged at 3000xg for 10 min. . 6 ). Thus, the activity described does not appear to bind to DNA sequences specific for these PyEC(F9) mutants, at least under conditions used here. On the other hand, cleavage by DNAase I at one site 15 nucleotides from the PyF441 point mutation was enhanced in the presence of F9 nuclear extract. Whether this is due to specific interaction of some factor(s) with these DNA sequences is not known.
Although no difference in binding was detected between wild-type and PyEC mutant enhancer sequences, a clear difference between these two DNAs was seen in either DNAase I or Exo III digestion patterns in the absence of nuclear extract. This difference in pattern was located around the PyF441 point mutation, suggesting that this region of mutant and wild-type DNAs may have conformational differences resulting from a single base pair transition. Conformational alteration of naked DNA due to deletion of three nucleotide pairs has been reported for a region upstream of the promoter for a tRNA operon in Salmonella (62). This mutation caused reduced transcription of the operon, suggesting a functional role of DNA conformation in gene expression. It is tempting to speculate that conformational features in DNA can be distinguished by nuclear factor(s) in F9 cells leading to differential expression of wild-type and mutant genomes in these cells. Alternatively, the differences in structure between wild-type and mutant enhancers observed in linear DNA under these u> vitro conditions may induce additional structural differences in vivo (for example, under torsional stress in supercoiled molecules; 63). These induced structural features could be recognized by nuclear factor(s).
A recent paper by Piette et a\_. How specific sequence alterations within the polyoma enhancer can lead to different host range properties is not known. As mentioned earlier, one possibility is the existence of cell type-specific trans-acting factors that bind to specific enhancer sequences. The enhancer-binding activity described here apparently does not show the specificity required of such a cell typespecific factor. At the same time, the observation that a point mutation in PyF441 DNA can cause changes in the cleavage pattern of DNAase I and the stop sites of Exo III in naked DNA when compared to wild-type polyoma DNA provides some basis for a mechanism involving interaction of cell type-specific factors with specific enhancer sequences. Of course, a binding assay alone is insufficient to elucidate the role(s) of putative trans-acting factors in regulation of gene expression. To identify and characterize these factors, it is necessary to develop an independent functional assay to carry out in parallel with binding studies. Only then can one begin to assess the possible functional role(s) of trans-acting factors in enhancer activity.
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